PIK3CA: Analysis of the PIK3CA mutation status Five samples (tissue preparations of HR-positive/HER2-negative breast cancer samples and/or other tumor entities); two unstained tissue slides each 5 µm thick are provided per sample Supplement AKT1/PTEN: Analysis of the AKT1/ PTEN mutation status Five samples (tissue preparations of HR-positive/HER2-negative breast cancer samples, endometrial cancer and/or other tumor entities); two unstained tissue slides each 5 µm thick are provided per sample
Please log in to view the proficiency test instructions.